Bristol-Myers Squibb Ups its Plans for China
July 15, 2011 at 06:59 AM EDT
Bristol-Myers Squibb expects China to become its second or third largest market within a decade. That’s a big jump from eighth place currently and a projected sixth next year. To get this task accomplished, BMS will increase its R&D staff in Shanghai, and it plans to increase its number of collaborations with domestic China pharmas. More details.... Stock Symbol: (NYSE: BMY) Share this with colleagues: